4.33
Precigen Inc (PGEN) 最新ニュース
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now? - Insider Monkey
Precigen, Inc. (PGEN) reports Q4 loss, lags revenue estimates - MSN
Precigen (NASDAQ: PGEN) 2026 proxy details director, pay and equity plan votes - Stock Titan
Precigen (PGEN) price target increased by 11.76% to 9.69 - MSN
Precigen gains after 2025 results on Papzimeos' outlook - MSN
These analysts boost their forecasts on Precigen following Q4 results - MSN
Top Growth Companies With Insider Stakes In April 2026 - simplywall.st
Precigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Precigen files to sell 143.81M shares of common stock for holders - MSN
Precigen (PGEN) Stock: Technical Risk Signals | Q4 2025: EPS Tops ViewsSocial Trade Signals - Cổng thông tin điện tử tỉnh Lào Cai
PGEN (Precigen) beats Q4 2025 EPS expectations, posts 146.7 percent revenue growth as shares rise 3.27 percent.Recovery Stocks - Cổng thông tin điện tử tỉnh Lào Cai
PGEN (Precigen Inc.) reports narrower Q4 2025 loss than estimates, shares rise slightly on positive investor sentiment.Consensus Forecast - UBND thành phố Hải Phòng
Precigen (PGEN) COO Rutul Shah receives new RSU and stock option grants - Stock Titan
Precigen (PGEN) awards RSUs and stock options to Chief Legal Officer - Stock Titan
Precigen (PGEN) CEO receives large RSU and stock option grants - Stock Titan
Precigen (PGEN) awards CCO 115,000 RSUs and 385,000 options - Stock Titan
Precigen (PGEN) CFO receives 120,000 RSUs and options on 399,000 shares - Stock Titan
Precigen expects Q1 revenue to exceed $18M as PAPZIMEOS launch accelerates with broad US payer coverage - MSN
Wall Street bullish on Precigen (PGEN) as the company transitions to commercial stage - MSN
Precigen (NASDAQ:PGEN) Trading Up 7.5%Still a Buy? - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Q4 2025 earnings call transcript - MSN
Is Precigen’s (PGEN) New PAPZIMEOS J-Code Reframing Its Respiratory Growth Narrative? - simplywall.st
Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million - ACCESS Newswire
Precigen (NASDAQ:PGEN) Trading Down 5.6%Here's Why - MarketBeat
Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy? - Insider Monkey
Aug Closing: Whats the fair value of Precigen Inc stockMarket Performance Recap & Expert Curated Trade Ideas - baoquankhu1.vn
Take Profit: Is Precigen Inc a turnaround storyWeekly Gains Summary & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Precigen, Inc. (PGEN) poised for growth on respiratory papillomatosis treatment prospects - MSN
Wall Street Bullish on Precigen (PGEN) As the Company Transitions to Commercial Stage - Insider Monkey
Take Profit: What are Precigen Incs recent SEC filings showingGap Down & Weekly High Conviction Trade Ideas - baoquankhu1.vn
CapEx per share of Precigen Inc – SWB:I5X - TradingView — Track All Markets
大文字化:
|
ボリューム (24 時間):